Nasdaq GlobeNewswire

Nasdaq CFO Lee Shavel to Present at 2015 Nasdaq Annual Investor Program in London


NEW YORK, 2015-11-25 18:52 CET (GLOBE NEWSWIRE) --  

Who: Nasdaq CFO Lee Shavel
What: 2015 Nasdaq Annual Investor Program in London
When: Wednesday, December 2, 2015
  3:45 PM GMT
Where: The May Fair Hotel
  Stratton Street, London, W1J 8LT, United Kingdom
Mr. Shavel's presentation will be webcast at:
Nasdaq's Investor Relations Website -


Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of approximately $8.8 trillion and more than 10,000 corporate clients. To learn more, visit: or


         Joseph Christinat
         Ed Ditmire, CFA

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

NRT Acquires OfferCraft, Award-Winning Provider of Artificial Intelligence, Gamification and Digital Content Solutions20.3.2018 14:22Pressemelding

Acquisition of hyper-engagement platform enhances NRT's ability to deliver transformative, revenue-generating technology to its customers LAS VEGAS, March 20, 2018 (GLOBE NEWSWIRE) -- NRT Technology Corp. ("NRT"), a leading provider of digital commerce experiences in gaming and financial services, announced that it has acquired the assets of privately held OfferCraft, a software company that uses artificial intelligence and gamification to drive loyalty, engagement and revenue. Terms of the agreement are not disclosed. The deal will allow NRT to integrate OfferCraft's patent-pending solutions into its existing kiosk, mobile, table games and cashless payment product lines, while also expanding into entirely new areas across nearly every digital channel. OfferCraft's artificial intelligence software allows offers, coupons and rewards to be distributed digitally across email, SMS, websites, social media, kiosks, the Point of Sale, signage, and more. Unlike traditional marketing content, t

Millennial Esports' Eden Games Amongst First Studios to Integrate Amazon GameOn20.3.2018 13:58Pressemelding

Millennial's game studio brings competitions to Gear.Club fans through Amazon GameOn TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Millennial Esports Corp. ("Millennial" or the "Company") (TSX VENTURE:GAME) (OTCQB:MLLLF), a mobile video game publisher focused on Esports and Racing, today announced that the Millennial Esports mobile racing game, Gear.Club, is expanding its gaming experience with the integration of Amazon GameOn, a new cross-platform competitive gaming service. After working with Amazon to integrate with this new service, Millennial Esports' game studio, Eden Games, was announced at the Game Developers Conference (GDC) on March 19 as one of the first game studios to build the service into one of their games. "Supported by this amazing new Amazon service, we can now offer daily Gear.Club Esports Racing competitions with real-world prizes fulfilled by Amazon. By being an early adopter of Amazon's cross-platform, competitive gaming service, we are excited to provide our fans

Elemica Releases New Connect and Automate Solutions for the Digital Supply Network20.3.2018 13:03Pressemelding

Elemica QuickLink Email P2P and Elemica QuickLink Email Logistics Provides Automated Purchase Order, Invoice, and Shipment Confirmations WAYNE, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Elemica, the leading Digital Supply Network for process manufacturers, announces new Elemica QuickLink solutions to help clients extend the connection and automation capabilities with their suppliers and logistics providers without requiring time-consuming integration services. The new Elemica QuickLink Email solutions allow clients to onboard their suppliers and logistics service providers cost effectively by connecting and automating their buying and shipping processes through email. Elemica QuickLink Email P2P enables buyers and suppliers to send and confirm purchase orders and invoices automatically with each other, while QuickLink Email Logistics allows shippers to request and confirm shipments with their logistics service providers through email. Supply chain partners that typically use manual proce

Genomatica brings its naturally sourced Brontide(TM) butylene glycol to Europe20.3.2018 13:00Pressemelding

Azelis chosen to distribute; already confirming better personal care formulations SAN DIEGO and ANTWERP, Belgium, March 20, 2018 (GLOBE NEWSWIRE) -- Genomatica, a widely-recognized technology leader for naturally sourced chemicals, and Azelis, a leading distributor of specialty chemicals, announced that Azelis is now the exclusive distributor for personal care applications of Genomatica's naturally sourced, award-winning Brontide(TM) butylene glycol in Europe. Azelis is already seeing widespread interest in Brontide from major brands and plans to support scores of major customers during Brontide's market introduction. See Brontide introduction video. Photos accompanying this announcement are available at A naturally sourced, sustainable cosmetics ingredient; Brontide honored for innovation Butylene glycol, a colo

LexinFintech Holdings Ltd. Reports Fourth Quarter and Full Year 2017 Unaudited Financial Results20.3.2018 12:22Pressemelding

SHENZHEN, China, March 20, 2018 (GLOBE NEWSWIRE) -- LexinFintech Holdings Ltd. ("Lexin" or the "Company") (NASDAQ:LX), a leading online consumer finance platform for educated young adults in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2017. Fourth Quarter and Full Year 2017 Operational Highlights: Total loan originations in 2017 reached RMB47.7 billion, representing an increase of 115% from RMB22.2 billion in 2016. Total outstanding principal balance of loans reached RMB19.3 billion as of December 31, 2017, representing an increase of 94.7% from RMB9.9 billion as of December 31, 2016. The weighted average tenor of loans originated on our platform in 2017 was approximately 9.53 months. The effective APR1 was 22.8% for the fourth quarter of 2017. Customer acquisition cost2 amounted to RMB99 in 2017, representing a decrease of 22% from 127 in 2016. Total number of registered users reached 23.9 million as of December 31, 20

Merus and the Vall d'Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer20.3.2018 12:00Pressemelding

UTRECHT, The Netherlands, March 20, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), and the Vall d'Hebron Institute of Oncology (VHIO), a leading comprehensive cancer center of excellence located in Barcelona, Spain, today announced a strategic research collaboration to develop novel agents for therapeutic applications. The collaboration will combine Merus' proprietary Biclonics® technology platform and VHIO's expertise in clinical, translational and preclinical research. Josep Tabernero, M.D., Ph.D., M.Sc., Director of VHIO, has served as a scientific advisor to Merus for the past six years. "VHIO is an internationally renowned leader in cancer research. This new collaboration builds on the successful working relationship established in the Phase 1/2 study for MCLA-128, a Biclonics® targeting HER3 signaling, and in the preclinical evaluation of MCLA-158, a Biclonics® target

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom